Literature DB >> 11731509

Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management.

C Miaskowski1, M J Dodd, C West, S M Paul, D Tripathy, P Koo, K Schumacher.   

Abstract

PURPOSE: To evaluate oncology outpatients' level of adherence to their analgesic regimen during a 5-week period. PATIENTS AND METHODS: A random sample of 65 adult oncology outpatients with a Karnofsky performance status score of >or= 50, an average pain intensity score of >or= 2.5, and radiographic evidence of bone metastasis were recruited for this longitudinal study from seven outpatient settings. On a daily basis, patients rated their level of pain intensity and recorded pain medication intake. Adherence rates for opioid analgesics prescribed on an around-the-clock (ATC) and on an as-needed (PRN) basis were calculated on a weekly basis.
RESULTS: Overall adherence rates for ATC opioid analgesics ranged from 84.5% to 90.8% and, for PRN analgesics, from 22.2% to 26.6%. No significant differences over time were found in either of these adherence rates.
CONCLUSION: One factor that seems to contribute to ineffective cancer pain management is poor adherence to the analgesic regimen.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731509     DOI: 10.1200/JCO.2001.19.23.4275

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  49 in total

1.  Long-term tolerability, efficacy and acceptability of fentanyl pectin nasal spray for breakthrough cancer pain.

Authors:  Lukas Radbruch; Luis M Torres; John E Ellershaw; Antonio Gatti; Guillermo Luis Lerzo; Julia Revnic; Donald Taylor
Journal:  Support Care Cancer       Date:  2011-03-22       Impact factor: 3.603

2.  A randomized trial of a representational intervention to decrease cancer pain (RIDcancerPain).

Authors:  Sandra Ward; Heidi Donovan; Sigridur Gunnarsdottir; Ronald C Serlin; Gary R Shapiro; Susan Hughes
Journal:  Health Psychol       Date:  2008-01       Impact factor: 4.267

3.  Prevalence and treatment of cancer pain in Italian oncological wards centres: a cross-sectional survey.

Authors:  Sebastiano Mercadante; Fausto Roila; Oscar Berretto; Roberto Labianca; Stefania Casilini
Journal:  Support Care Cancer       Date:  2008-05-14       Impact factor: 3.603

Review 4.  A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs.

Authors:  Charles E Argoff; Daniel I Silvershein
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

5.  Adherence to Analgesics for Cancer Pain: A Comparative Study of African Americans and Whites Using an Electronic Monitoring Device.

Authors:  Salimah H Meghani; Aleda M L Thompson; Jesse Chittams; Deborah W Bruner; Barbara Riegel
Journal:  J Pain       Date:  2015-06-14       Impact factor: 5.820

6.  Patient Patterns and Perspectives on Using Opioid Regimens for Chronic Cancer Pain.

Authors:  Emily M Wright; Areej El-Jawahri; Jennifer S Temel; Alaina Carr; Steven A Safren; Elyse R Park; William F Pirl; Eduardo Bruera; Lara Traeger
Journal:  J Pain Symptom Manage       Date:  2019-03-01       Impact factor: 3.612

7.  Assessment of pain and analgesic use in African American cancer patients: factors related to adherence to analgesics.

Authors:  Young O Rhee; Eugenia Kim; Bryant Kim
Journal:  J Immigr Minor Health       Date:  2012-12

8.  Out-of-pocket prices of opioid analgesics in the United States, 1999-2004.

Authors:  Benjamin M Craig; Scott A Strassels
Journal:  Pain Med       Date:  2009-12-09       Impact factor: 3.750

9.  An examination of adherence to pain medication plans in older cancer patients in hospice care.

Authors:  Sara Sanders; Keela A Herr; Perry G Fine; Catherine Fiala; Xiongwen Tang; Chris Forcucci
Journal:  J Pain Symptom Manage       Date:  2012-07-26       Impact factor: 3.612

10.  Randomized clinical trial of an intensive nursing-based pain education program for cancer outpatients suffering from pain.

Authors:  Evelien H van der Peet; Marieke H J van den Beuken-van Everdingen; Jacob Patijn; Harry C Schouten; Maarten van Kleef; Annemie M Courtens
Journal:  Support Care Cancer       Date:  2008-12-23       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.